Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.
Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.
The price of argatroban ...
Table of Contents
2019-2024 Global Argatroban Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Argatroban Consumption 2014-2024
2.1.2 Argatroban Consumption CAGR by Region
2.2 Argatroban Segment by Type
2.2.1 Argatroban Powder
2.2.2 Argatroban Injection
2.3 Argatroban Consumption by Type
2.3.1 Global Argatroban Consumption Market Share by Type (2014-2019)
2.3.2 Global Argatroban Revenue and Market Share by Type (2014-2019)
2.3.3 Global Argatroban Sale Price by Type (2014-2019)
2.4 Argatroban Segment by Application
2.4.1 Heparin-induced thrombocytopenia (HIT)
2.4.2 Percutaneous Coronary Intervention
2.4.3 Cerebral arterial thrombosis
2.5 Argatroban Consumptio ...